What it is
A synthetic tripeptide (Glu-Asp-Arg) developed in Russia as one of the Khavinson short peptides, derived from pineal-gland-related sequences.
How it works
Hypothesized in preclinical studies to penetrate cell nuclei and modulate gene expression and oxidative stress, though human pharmacokinetics are poorly characterized.
Where it's used
Studied in Russian research literature for proposed effects on cognition and aging biomarkers; not approved as a drug outside that context.
Regulatory status
Not FDA-approved; research compound.
Reconstitution
Supplied as a lyophilized powder requiring reconstitution with bacteriostatic water prior to use.
Tracking it
Pinealon is injectable, so two things matter in a log: when you dosed and where. Rotating sites and writing both down prevents the classic “did I already pin the left side?” problem.
Source
Public reference
Last reviewed 2026-06-11